Allena Pharmaceuticals, Inc.
ALNAQ · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,435 | -$11,813 | $5,455 | -$12,692 |
| Dep. & Amort. | $118 | $125 | $122 | $96 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $560 | $617 | $809 | $1,035 |
| Change in WC | $3,200 | -$9,104 | -$3,475 | -$29 |
| Other Non-Cash | $0 | $138 | -$15,714 | $113 |
| Operating Cash Flow | -$4,557 | -$20,037 | -$12,803 | -$11,477 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$25 | -$185 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$25 | -$185 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,944 | $3,944 | $41,273 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,693 | -$1,056 | $2,395 | $25,427 |
| Financing Cash Flow | $2,251 | -$1,056 | $2,395 | $25,427 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,306 | -$21,093 | -$10,433 | $13,765 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,895 | $29,988 | $40,421 | $26,656 |
| End Cash | $6,589 | $8,895 | $29,988 | $40,421 |
| Free Cash Flow | -$4,557 | -$20,037 | -$12,828 | -$11,662 |